Adial Pharmaceuticals Inc [NASDAQ: ADIL] traded at a high on Wednesday, posting a 85.50 gain after which it closed the day’ session at $1.62. The company report on February 28, 2024 at 9:30 AM that Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office.
New patent strengthens Adial’s patent portfolio and covers AD04’s unique ability to target the serotonin transporter gene for the potential treatment of opioid use disorder.
The results of the trading session contributed to over 111400995 shares changing hands. Over the past one week, the price volatility of Adial Pharmaceuticals Inc stands at 50.97% while the volatility over the past one month is 27.35%.
The market cap for ADIL stock reached $2.69 million, with 1.66 million shares outstanding and 1.51 million shares in the current float. Compared to the average trading volume of 305.79K shares, ADIL reached a trading volume of 111400995 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Adial Pharmaceuticals Inc [ADIL]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ADIL shares is $26.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ADIL stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Adial Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 30, 2018. While these analysts kept the previous recommendation, Dawson James raised their target price to Buy. The new note on the price target was released on October 11, 2018, representing the official price target for Adial Pharmaceuticals Inc stock.
The Average True Range (ATR) for Adial Pharmaceuticals Inc is set at 0.32 The Price to Book ratio for the last quarter was 0.84, with the Price to Cash per share for the same quarter was set at 0.19.
How has ADIL stock performed recently?
Adial Pharmaceuticals Inc [ADIL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 72.34. With this latest performance, ADIL shares gained by 30.65% in over the last four-week period, additionally sinking by -51.50% over the last 6 months – not to mention a drop of -85.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADIL stock in for the last two-week period is set at 66.59, with the RSI for the last a single of trading hit 74.95, and the three-weeks RSI is set at 59.80 for Adial Pharmaceuticals Inc [ADIL]. The present Moving Average for the last 50 days of trading for this stock 1.3859, while it was recorded at 0.9957 for the last single week of trading, and 3.5707 for the last 200 days.
Adial Pharmaceuticals Inc [ADIL]: Deeper insight into the fundamentals
Adial Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.15 and a Current Ratio set at 2.15.
Earnings analysis for Adial Pharmaceuticals Inc [ADIL]
With the latest financial reports released by the company, Adial Pharmaceuticals Inc posted -2.75/share EPS, while the average EPS was predicted by analysts to be reported at -3.75/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 26.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ADIL.
Insider trade positions for Adial Pharmaceuticals Inc [ADIL]
The top three institutional holders of ADIL stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in ADIL stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in ADIL stock with ownership which is approximately 5.8325%.
